{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:38:52Z","timestamp":1769456332108,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Robert Austrian Research Award"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T20:46:00Z","timestamp":1477169160000},"page":"5929-5937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial"],"prefix":"10.1016","volume":"34","author":[{"given":"M.","family":"Tashani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alfelali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Barasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Booy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.020_b0005","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/15680266113136660180","article-title":"Novel strategies for development of next-generation glycoconjugate vaccines","volume":"13","author":"Avci","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.vaccine.2016.10.020_b0010","series-title":"Vaccine analysis: strategies, principles, and control","first-page":"301","article-title":"Glycoconjugate vaccines","author":"Ravenscroft","year":"2015"},{"key":"10.1016\/j.vaccine.2016.10.020_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.020_b0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0025","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1586\/erv.11.142","article-title":"Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules","volume":"10","author":"Borrow","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.020_b0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0035","series-title":"The Australian immunisation handbook, 10th ed.","author":"Australian Technical Advisory Group on Immunisation (ATAGI)","year":"2015"},{"key":"10.1016\/j.vaccine.2016.10.020_b0040","unstructured":"Nahm MH, Burton RL. Protocol for opsonophagocytic killing assay for antibodies against Group B Streptococcus (UAB GBS OPA); 2013."},{"key":"10.1016\/j.vaccine.2016.10.020_b0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CVI.00344-08","article-title":"Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A","volume":"16","author":"Lee","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.10.020_b0050","series-title":"Pneumococcal conjugate vaccines: Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines","author":"WHO","year":"2009"},{"key":"10.1016\/j.vaccine.2016.10.020_b0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(96)91456-7","article-title":"Diphtheria immunity in health staff","volume":"347","author":"John","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.020_b0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0092-1157(86)90008-9","article-title":"ELISA for the routine determination of antitoxic immunity to tetanus","volume":"14","author":"Simonsen","year":"1986","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2016.10.020_b0065","first-page":"274","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region","volume":"25","year":"2000","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2016.10.020_b0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Marcy","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0075","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.020_b0080","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1016\/j.vaccine.2015.08.080","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18\u201349years of age, naive to 23-valent pneumococcal polysaccharide vaccine","volume":"33","author":"Bryant","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0085","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/iai.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0090","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/420849","article-title":"Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria\/tetanus-conjugated vaccine: a randomized controlled trial","volume":"189","author":"Lucero","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.020_b0095","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.2013.228052","article-title":"Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial","volume":"310","author":"Spijkerman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.10.020_b0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5409\/wjcp.v5.i3.311","article-title":"Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction","volume":"8","author":"Tashani","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.vaccine.2016.10.020_b0105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.020_b0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/00365540110026502","article-title":"Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults","volume":"33","author":"Shelly","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.020_b0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(96)00025-4","article-title":"Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy","volume":"14","author":"Kurikka","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/168.3.663","article-title":"Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines","volume":"168","author":"Granoff","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.020_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/iai.62.1.9-14.1994","article-title":"Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine","volume":"62","author":"Barington","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/iai.61.2.432-438.1993","article-title":"Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components","volume":"61","author":"Barington","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0135","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0140","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.1996.03530390048033","article-title":"Maternal immunization with Haemophilus influenzae type b polysaccharide\u2014tetanus protein conjugate vaccine in The Gambia","volume":"275","author":"Mulholland","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.10.020_b0145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0150","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0155","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.020_b0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.10.020_b0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/CVI.00315-09","volume":"17","author":"Moss","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.10.020_b0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.020_b0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1995.tb44436.x","article-title":"Potential alterations in immunogenicity by combining or simultaneously administering vaccine components","volume":"754","author":"Insel","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2016.10.020_b0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/21645515.2015.1091908","article-title":"Interactions of conjugate vaccines and co-administered vaccines","volume":"12","author":"Findlow","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.10.020_b0185","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0190","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.72.8.4884-4887.2004","article-title":"N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines","volume":"72","author":"Baraldo","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.020_b0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CVI.00516-10","article-title":"Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age","volume":"18","author":"Miller","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.10.020_b0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0264-410X(01)00375-9","article-title":"Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers","volume":"20","author":"Olander","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.020_b0205","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:05:32Z","timestamp":1668639932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":41,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X16309367"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}